The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Headline
The Food and Drug Administration has issued an early alert for all heart pump controllers by Abiomed, which sent a correction notice to all customers with…
Headline
Microsoft announced May 19 that it disrupted operations of Fox Tempest, a threat actor operating as a malware-signing-as-a-service used by cybercriminals to…
Headline
An AHA Cyber & Risk Intel blog by John Riggi, AHA national advisor for cybersecurity and risk, explores what health care leaders need to consider to reduce…
AHA Cyber Intel
Cyberattacks against hospitals, health systems and mission-critical health care third-party providers have surged in recent years. While these attacks often…
Headline
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy…
Headline
Microsoft Threat Intelligence is warning of a large scale, multistage phishing campaign that disproportionately targeted the health care sector, sending “code…